More evidence for the benefits of aggressive lipid-lowering with statins has come from the IDEAL study, which randomised nearly 9000 post-MI patients to either 80 mg of atorvastatin or 20/40 mg simvastatin daily. Terje Pedersen from Ulleval University Hospital in Norway presented the findings.
Anthony Bavry, The Cleveland ClinIc, OH
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 821-5
All cause
Donald Redelmeier, University of Toronto
Abstract: Lancet 2006; 367:413
Treatment with the lipid lowering agents statins reduced the incidence of sepsis among
Post a comment